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Abstract:  
Objective: Stroke is a major health problem, yet no studies on stroke have been reported from Palestine. This one-year, 
hospital-based study was conducted to determine the prevalence of risk factors and the in-hospital mortality rate in patients 
with ischemic stroke. Method: All patients admitted to Al-Watani government hospital and diagnosed with ischemic stroke 
between September 2006 and August 2007 were included in the study. Data were obtained by retrospective review of 
medical charts. Pearson Chi-square and independent t test were used in the univariate analysis. Multiple logistic regression 
analysis was used to determine the independent predictors of in-hospital mortality rates among the patients. Statistical testing 
and graphics were carried out using SPSS 15. Results: We identified 153 ischemic stroke patients (83 females and 70 males) 
of whom 92 were having a first-ever stroke (FES). Patients had several prevalent modifiable risk factors such as hypertension 
(HTN) (66%), diabetes mellitus (DM) (45.8%), and renal reduced renal function (crcl < 60 ml/ min) (33.9%). Twenty-six 
(17%) of the patients died during hospitalization. Four variables were significantly associated with in-hospital mortality: 
history of previous stroke (P= 0.004), crcl at admission (P=0.004), number of post-stroke complications (P=0.001), and age 
(P=0.043). Multiple logistic regression analysis indicated that the number of post-stroke complications (P= 0.001) and 
previous stroke (P=0.03) were significant independent predictors of in-hospital mortality. Conclusion: Screening and better 
control of risk factors, especially HTN, DM and renal dysfunction, are required to decrease the incidence and in-hospital 
mortality among patients with ischemic stroke. 
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Introduction 
Studies have demonstrated that different ethnic groups 
may have different predisposing risk factors, epidemiologic 
patterns, and outcomes of stroke. This has been shown in 
African Americans, Caucasians, Hispanics, Arabs, and 
Asians [1-6]. These differences could be due to 
differences in demographic or socioeconomic factors or in 
lifestyle. Although epidemiologic studies on stroke were 
carried out in different parts of the world, including some 
Arab countries [7-11], there are no published data about 
Palestine. Data on stroke epidemiology are important for 
diagnostic, therapeutic and preventive purposes. 
Furthermore, knowledge of the prevalence of stroke-
related risk factors can help health decision makers to 
direct efforts toward reducing stroke-related morbidity and 
mortality.  
 
In Palestine, the Ministry of Health is the major provider 
of medical services. The private sector plays a minor role 
due to its high cost compared to the average income in 
Palestine. Currently, the Palestinian National Authority is in 
charge of West-bank and Gaza strip, with a total 
population of 4,151,668 inhabitants. The West Bank is 
divided into 10 districts. Nablus district is the second 
largest district with a population of 362,159 native 
Palestinian inhabitants. This study was conducted to 
identify the risk factors, in-hospital mortality, and 
discharge medications for patients with ischemic stroke 
admitted to Al-Watani government hospital, Nablus, 
Palestine.  
 
Methods and patients 
This one-year, retrospective, hospital-based study was 
conducted between September 01, 2006 and August 31, 
2007. All patients admitted to the hospital with acute 
ischemic stroke were included in the study. Diagnosis of 
ischemic stroke had been confirmed by computerized 
tomography (CT) scan. Each diagnosed patient had been 
followed up until either death at the hospital or discharge. 
Data collection was approved by the health authorities at 
the hospital.  
 
The data were collected by retrospective review of 
medical charts included age, gender, medications, serum 
creatinine (scr) level, risk factors, and post-stroke medical 
complications. Then following were considered risk 
factors:  age, hypertension (HTN), diabetes mellitus (DM), 
congestive heart failure (CHF), atrial fibrillation (AF), 
ischemic heart disease (IHD), smoking, previous stroke, 
and obesity [12-15]. Hyperlipidemia is a risk factor for 
stroke, but we did not include it because it had not been 
done routinely at the hospital. Obesity was defined as a 
body mass index (BMI) >30 for both genders. Creatinine 
clearance (crcl) was calculated by using Cokcroft-Gault 
equations, and values for females were obtained by 
multiplying the result by 0.85. The number of post-stroke 
complications was counted for each patient. The post-
stroke complications considered were the presence of one 
or more of the following: constipation, seizure, depression, 
infection, limb pain, and gastrointestinal upset. 
 
Statistical analysis 
Analysis of data was carried out using the "Statistical 
Package for Social Sciences" (SPSS) program for Windows 
version 15.0 (SPSS Inc., Chicago, IL). Univariate analysis 
was carried out using Pearson Chi-square for categorical 
variables and student’s t test for continuous variables. P 
<0.05 was used as a significance level. Multiple logistic 
regression analysis was used to find independent 
predictors of in-hospital mortality. Variables included in 
the regression model were those that had a significant P 
value (P<0.05) in the univariate analysis.  
 
Results 
We found that 186 stroke patients were admitted to the 
hospital during the study period; of these, we studied 153 
who were diagnosed with ischemic stroke. All patients 
were admitted within 48 hours of the attack. The average 
age of the patients was 69.08± 11.15 years (range 41-
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90). Less than 2% of the patients were < 45 years old. 
45.8% were males and 54.2% were females, giving a 
male:female ratio of 0.84:1. There was no significant 
difference between females and males in age. Among the 
patients, 39.9% had previous attack, and 60.1% had a 
first ever stroke (FES). Patients with FES were younger 
than those with recurrent stroke (67.94 ± 11.66 versus 
70.80 ± 10.19 years, respectively); the difference in age 
between the two groups was not significant (P = 0.11). 
 
The prevalence of risk factors in the study sample was 
investigated (Figure 1). Patients had an average of 3.4 ± 
1.2 risk factors (range 1 – 7) before the attack. HTN was 
the most prevalent risk factor (66%) of the patients, 
followed by DM (45.8%). Renal dysfunction was also 
common: 33.9% of the patients had an estimated crcl < 
60 ml/min. Smoking was practiced by 19.6% of the 
patients, most of whom (99%) were males. AF was found 
in 16.3% of patients. No significant difference was found 
in the prevalence of risk factors between males and 
females, with the exception of smoking which was 
significantly associated with males. However, CHF and DM 
were more common in females, while HTN was more 
common in males.  
 
Twenty-six (17%) of the patients died during 
hospitalization. Of the 127 survivors, three left the hospital 
against medical advice and 124 continued treatment until 
discharge. Four variables were significantly associated 
with in-hospital mortality: history of previous stroke (P= 
0.004), crcl at admission (P=0.004), number of post-
stroke complications (P=0.001), and age (P=0.043). 
Gender, HTN and DM were insignificantly associated with 
mortality. Multiple logistic regression analysis indicated 
that the number of post-stroke complications (P= 0.001) 
and previous stroke (P=0.03) were significant independent 
predictors of in-hospital mortality. Table 1 summarizes the 
demographic and clinical characteristics of patients who 
survived versus those who died. Table 2 shows multiple 
logistic regression model using the enter method for 
predicting mortality after stroke.  
 
Medications prescribed for stroke survivors at discharge 
were analyzed.  An average of 4.33 medications (SD = 
1.5, range: 1 - 9) were prescribed per stroke survivor. The 
medications prescribed were from six different therapeutic 
drug classes. Seventy-four (92.5%) stroke survivors with a 
diagnosis of hypertension were discharged on 
antihypertensive medications. ACE-I were the most (n = 
62, 50%) was the class of antihypertensive agents most 
frequently prescribed for stroke survivors. Medications 
prescribed at discharge were similar to those given at 
admission. The main exceptions were anti-coagulants, 
antibiotics, and anti-inflammatory agents, all of which 
were used at admission but were discontinued at 
discharge. Most patients (98%) were discharged with anti-
platelets. There was no difference in the average number 
of medications prescribed for males and females at 
discharge (P= 0.36).  
 
 
Figure 1 Prevalence of various risk factors in the stroke patients 
admitted to the hospital during the study period. HTN: 
hypertension, DM: diabetes mellitus, BMI: body mass index, AF: 
atrial fibrillation, CHF: congestive heart failure, IHD: ischemic 
heart disease  
  
Table 1 Results of univariate analysis of 153 ischemic stroke 








Age   73.11 ± 11.19  68.26 ± 11.01  0.043* 
Creatinine 
clearance 
61.63 ± 41.97  90.64± 50.79  0.004* 
Post-stroke 
complication 
1.73± 1.15  0.86 ± 0.92  0.001* 
Gender 







71 (55.9%)  0.36 
HTN  19 (73.1%)  82 (64.6%)  0.40 
DM  15 (57.9%)  55 (43.3%)  0.18 
Previous 
stroke 
17 (65.4%)  44 (34.6%)  0.004 
Previous 
Anti-platelet 
19 (73.1%)  74 (58.3%)  0.159 
AF  4 (15.4%)  21 (16.5%)  0.885 
Smoking  7 (26.9%)  23 (18.1%)  0.302 
IHD  3 (11.5%)  8 (6.3%)  0.346 
CHF  3 (11.5%)  17 (13.4%)  0.799 
Obesity  12 (46.1%)  46 (36.2%)  0.263 
HTN: hypertension, DM: diabetes mellitus, AF: Atrial fibrillation, IHD: 
ischemic heart disease, CHF: congestive heart failure. Continuous variables 
were expressed as mean ± SD, while categorical variables were expressed 
as frequency and percentage. P value was calculated using independent t 
test for continuous variables and Chi-square test for categorical variables. 
 
Table 2  Multiple logistic regression by the enter method for 
identifying predictors of mortality after ischemic stroke. 





Age   .001  0.003  0.677  [-0.005 – 0.007] 
Creatinine 
clearance 
-0.001  0.001  0.148  [-0.002 – 0.000] 
No. of 
complications 
 .099  0.029  0.001  [0.041 – 0.156] 
Previous stroke   .131  0.060  0.032  [0.012 – 0.250] 
 
Discussion 
We studied the characteristics of patients with ischemic 
stroke attacks at Al-watani hospital, Palestine. The mean 
age was higher than that reported in hospital-based 
studies from some other Arab countries but lower than 
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that reported from developed countries [16,17]. An 
important observation is the very low percentage (1.6%) 
of stroke patients who were less than 45 years old. The 
prevalence of stroke in young patients seems to vary 
between different ethnic groups of various geographical 
areas. For instance, only 3–5% of all strokes occurred in 
individuals under 45 years old in some countries, while in 
others they constituted as much as 19–30% [18-20]. The 
male:female (M:F) ratio of 0.84:1 in this study was not in 
agreement with previous studies on stroke from other 
countries. One study in a province of Saudi Arabia found a 
M:F ratio of 1.8:1. A second study among the National 
Guard community in Saudi Arabia found a M:F ratio of 
2.2:1. A third study in Saudi Arabia found a ratio of 3.4:1 
[21-23].  However, a hospital-based study in Saudi Arabia 
found a 1:1 male: female ratio in stroke patients in 
general [24]. The unexpected gender ratio in our study 
might indicate the presence of undiagnosed or 
uncontrolled stroke-related risk factors in women in 
Palestine.  
 
The high prevalence of risk factors among the stroke 
victims indicates that control of these factors is important 
for the prevention of stroke. Thus, screening, modification, 
and better control of existing risk factors, such as HTN, 
DM, and cardiac diseases, should be the primary strategy 
for prevention of stroke. Prospective observational studies 
have established that the risk of primary stroke is strongly 
related to blood pressure (BP) [25]. Lowering diastolic BP 
by 5 mmHg or systolic BP by 10 mmHg reduces the risk of 
stroke by an estimated 38% [26]. In our study, most 
patients with HTN were given anti-hypertensive agents, 
particularly ACE-I, at discharge. About one-third of the 
patients had an estimated crcl < 60 ml/min. A recent 
study indicated that mild degrees of renal dysfunction are 
associated with increased risk of incident ischemic stroke 
or transient ischemic attack [27]. Recent studies have also 
established that patients with end stage renal disease 
(ESRD) have 5–10–fold higher risk of stroke compared to 
patients with non-ESRD [28,29].      
 
Results of in-hospital mortality among stroke patients in 
this study were also close to those reported in most Arab 
countries. Four variables were significant risk factors of in-
hospital mortality in stroke patients, namely, history of 
previous stroke, number of post-stroke complications, 
creatinine clearance, and age. The influence of age on 
stroke outcome is still a matter of debate. While several 
studies showed a negative influence, other studies showed 
no influence [30-38]; our results resemble those that 
showed a negative influence of age on stroke outcome. It 
is difficult to establish whether age influences stroke 
outcome itself, or through other factors associated with 
age. Our finding regarding crcl as an independent 
predictor of early mortality in stroke patients is endorsed 
by some studies. For example, a study by Friedman in 
1991 indicated that serum creatinine was an independent 
predictor of mortality among 492 stroke survivors followed 
up for a mean period of 18 months [39]. Another 7-year 
follow up study carried out by MacWalter et al. in 2002 
indicated that patients with creatinine clearance calculated 
at admission of < 51 ml/min had a higher mortality rate 
[40]. Finally, a recent study by Fabjan et al. indicated that 
in patients with ischemic stroke, decreased crcl was 
associated with higher in-hospital mortality [41].  
Interestingly, we found that prior use of anti-platelets 
was not associated with decreased risk of mortality. A 
hospital-based study carried out in Kuwait found that non-
se of anti-platelets is significantly associated with 
deleterious 30-day outcome [42]. One way to reduce early 
mortality in stroke patients is to develop a stroke unit 
supervised by a specialized neurologist. Admission of 
acute stroke patients into specialized hospitals seems to 
reduce the risk of in-hospital mortality [43]. Moreover, 
academic medical centers with vascular neurologists had 
lower rates of in-hospital mortality for patients with 
ischemic stroke [44]. It seems that mortality in patients 
with stroke does not depend only on patient-related 
factors but also on hospital characteristics. 
 
Conclusion 
Most of the patients in the study had risk factors 
commonly present in stroke patients. Better control of 
these risk factors might decrease the future incidence rate 
of stroke in Palestine. The number of post-stroke 
complications and previous stroke were significant 
independent predictors of in-hospital mortality. 
Medications prescribed at discharge for stroke survivors 
are consistent with the type of risk factors, especially HTN, 
present in patient’s medical files.  
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